Examining the use of glucose and physical activity self-monitoring technologies in individuals at moderate to high risk of developing type 2 diabetes: randomized trial by Maxine E Whelan (8504874) et al.
Original Paper
Examining the Use of Glucose and Physical Activity
Self-Monitoring Technologies in Individuals at Moderate to High
Risk of Developing Type 2 Diabetes: Randomized Trial
Maxine E Whelan1,2,3, BSc, PhD; Mark W Orme2,3,4,5, BSc, PhD; Andrew P Kingsnorth2,3, BSc, MSc, PhD; Lauren
B Sherar2,3,6, BSc, MSc, PhD; Francesca L Denton2,3, BSc; Dale W Esliger2,3,6, BSc, MSc, PhD
1Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom
2National Centre for Sport and Exercise Medicine, Loughborough University, Loughborough, United Kingdom
3School of Sport, Exercise and Health Sciences, Loughborough University, Loughborough, United Kingdom
4Department of Respiratory Sciences, University of Leicester, Leicester, United Kingdom
5Centre for Exercise and Rehabilitation Science, National Institute for Health Research Leicester Biomedical Research Centre-Respiratory, Leicester,
United Kingdom
6National Institute for Health Research Leicester Biomedical Research Centre-Lifestyle, Leicester, United Kingdom
Corresponding Author:
Maxine E Whelan, BSc, PhD
Nuffield Department of Primary Care Health Sciences
University of Oxford
Radcliffe Observatory Quarter
Woodstock Road
Oxford, OX2 6GG
United Kingdom
Phone: 44 7435330992
Email: maxine.whelan@phc.ox.ac.uk
Abstract
Background: Self-monitoring of behavior (namely, diet and physical activity) and physiology (namely, glucose) has been
shown to be effective in type 2 diabetes (T2D) and prediabetes prevention. By combining self-monitoring technologies, the acute
physiological consequences of behaviors could be shown, prompting greater consideration to physical activity levels today, which
impact the risk of developing diabetes years or decades later. However, until recently, commercially available technologies have
not been able to show individuals the health benefits of being physically active.
Objective: The objective of this study was to examine the usage, feasibility, and acceptability of behavioral and physiological
self-monitoring technologies in individuals at risk of developing T2D.
Methods: A total of 45 adults aged ≥40 years and at moderate to high risk of T2D were recruited to take part in a 3-arm feasibility
trial. Each participant was provided with a behavioral (Fitbit Charge 2) and physiological (FreeStyle Libre flash glucose monitor)
monitor for 6 weeks, masked according to group allocation. Participants were allocated to glucose feedback (4 weeks) followed
by glucose and physical activity (biobehavioral) feedback (2 weeks; group 1), physical activity feedback (4 weeks) followed by
biobehavioral feedback (2 weeks; group 2), or biobehavioral feedback (6 weeks; group 3). Participant usage (including time spent
on the apps and number of glucose scans) was the primary outcome. Secondary outcomes were the feasibility (including recruitment
and number of sensor displacements) and acceptability (including monitor wear time) of the intervention. Semistructured qualitative
interviews were conducted at the 6-week follow-up appointment.
Results: For usage, time spent on the Fitbit and FreeStyle Libre apps declined over the 6 weeks for all groups. Of the FreeStyle
Libre sensor scans conducted by participants, 17% (1798/10,582) recorded rising or falling trends in glucose, and 24% (13/45)
of participants changed ≥1 of the physical activity goals. For feasibility, 49% (22/45) of participants completed the study using
the minimum number of FreeStyle Libre sensors, and a total of 41 sensors were declared faulty or displaced. For acceptability,
participants wore the Fitbit for 40.1 (SD 3.2) days, and 20% (9/45) of participants and 53% (24/45) of participants were prompted
by email to charge or sync the Fitbit, respectively. Interviews unearthed participant perceptions on the study design by suggesting
refinements to the eligibility criteria and highlighting important issues about the usability, wearability, and features of the
technologies.
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Conclusions: Individuals at risk of developing T2D engaged with wearable digital health technologies providing behavioral
and physiological feedback. Modifications are required to both the study and to commercially available technologies to maximize
the chances of sustained usage and behavior change. The study and intervention were feasible to conduct and acceptable to most
participants.
Trial Registration: International Standard Randomized Controlled Trial Number (ISRCTN) 17545949;
isrctn.com/ISRCTN17545949
(JMIR Mhealth Uhealth 2019;7(10):e14195)  doi: 10.2196/14195
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Introduction
The prevalence of diabetes was estimated to be more than 3
million in England in 2017 [1]. It is a fast-growing health crisis
in the United Kingdom and globally [2], but given that 3 out of
5 cases of type 2 diabetes (T2D) are preventable [3], efforts to
prevent the onset of T2D in people identified at increased risk
are a clear public health priority.
The British Medical Association reported in 2018 the need to
prioritize prevention over cure for long-term conditions to secure
the long-term sustainability of the National Health Service
(NHS). In parallel, the NHS Long Term Plan outlined the need
to promote digitally enabled care and patient empowerment
around accessing digital tools [4]. NHS Digital is a key driving
force attempting to harness the power of information and
technology into existing health care pathways, using
technologies such as wearables and Web-based platforms. In
combination, the ability to self-monitor behavior and health
using wearables has created new opportunities for people to
actively participate in their health care in nonclinical settings
[5,6].
Flash glucose monitoring (FGM), brought onto the market in
2016, allows users to monitor their interstitial glucose
fluctuations. Early studies have demonstrated reductions in
hypoglycemia, increased time spent in the target range, and
greater levels of patient satisfaction compared with traditional
fingerstick monitoring for individuals living with type 1 diabetes
and T2D [7,8]. However, this technology has not been examined
in the context of diabetes prevention.
In parallel, physical activity has an important role in disease
prevention [9] and is a major risk factor for long-term conditions
including T2D [10]. In the laboratory setting, brief bouts of
physical activity have resulted in acute reductions in
postprandial glucose and insulin in normal weight, overweight,
and obese adults [11-13]. With commercially available
technologies increasingly capable of monitoring real-time
physical activity and glucose levels, it is an exciting opportunity
to see changes in glucose in relation to physical activity outside
of the laboratory setting. Even if people are not diagnosed with
T2D, a relationship between physical activity and glucose still
exists, which means those at risk could also be targeted as a
preventative strategy. This approach could offer a unique
opportunity for individuals to see these relationships in a
real-world setting, which could influence their daily behaviors
and subsequently their acute health.
The Sensing Interstitial Glucose Levels to Nudge Active
Lifestyles (SIGNAL) study examined the usage of FGM and
physical activity self-monitoring technologies for people
identified as moderate to high risk of developing T2D.
Secondary objectives were to assess the feasibility and
acceptability of the trial design, recruitment, methodology, and
technology. Interviews with participants were also conducted
to understand their perspectives of using self-monitoring
technologies in the context of T2D prevention. Assessing the
feasibility was crucial to evaluate whether a full trial would be
feasible.
Methods
Study Design
This trial was a randomized, 3-arm feasibility trial. The full
protocol has been published [14], and the study was registered
prospectively (ISRCTN17545949). All participants provided
written informed consent. Loughborough University’s Ethics
Advisory Committee provided ethical approval for the study
(reference R17-P049).
Participants and Setting
Participants were recruited between May and September 2017
by circulating posters, letters, and emails across Leicestershire,
United Kingdom. In brief, participants were aged ≥40 years and
owned a compatible Android smartphone. Participants must not
have had a self-reported diagnosis of diabetes (type 1, type 2,
or gestational) or a glycated hemoglobin (HbA1c) measurement
of ≥6.5%. Interested individuals were directed to complete the
Leicester Risk Assessment, which is a validated tool [15] to
determine the level of risk for T2D via a Web-based survey
(Qualtrics; Multimedia Appendix 1). Questions included age,
sex, ethnic background, waist circumference, height, weight,
and family history of diabetes. After completing the Web-based
survey, individuals who received a score of moderate (16-24
points) or high (≥25/47 points) risk were contacted by a
researcher by telephone or email and subsequently sent the
participant information sheet by email if they were interested
in taking part. An in-person appointment was scheduled at
Loughborough University if participants continued to express
an interest in taking part after reading the participant information
sheet. During this in-person appointment, a point-of-care
measurement of HbA1c was taken to confirm eligibility before
obtaining consent.
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Randomization and Masking
An independent researcher produced a computer-generated
randomization list with 1:1:1 allocation. After the researcher
confirmed eligibility, group allocation was revealed to the
participant. The researcher was informed of the participant’s
allocation on the day of the appointment to ensure adequate
preparation (study paperwork and equipment needs varied
between treatment allocations), meaning it was not possible to
blind the researcher or participant to treatment allocation.
Participants were encouraged to use the self-monitoring
technologies as they wished, with no expectation or judgment
from the researchers.
Interventions
Participants were allocated to 1 of the 3 6-week interventions
(Figure 1). The 3 groups were developed so that usage could
be identified for participants accessing glucose feedback alone,
physical activity feedback alone, and both types of feedback
(in parallel). The authors anticipated that usage would be higher
in group 3 than in groups 1 and 2 from the start of the
intervention. Group 1 participants were given access to glucose
feedback by the FreeStyle Libre (Abbott Diabetes Care) for the
first 4 weeks. In the remaining 2 weeks, these participants could
access physical activity feedback by the Fitbit Charge 2 (Fitbit
Inc; from here on simply referred to as Fitbit) in parallel (hereon
Group 1 will be referred to as G4GPA2). Group 2 participants
were given feedback by the Fitbit for the first 4 weeks before
also accessing feedback from the FreeStyle Libre (as well as
the Fitbit) for the remaining 2 weeks (hereon Group 2 will be
referred to as PA4GPA2). Group 3 participants were given
feedback from both the FreeStyle Libre and Fitbit (in parallel)
for the full 6 weeks (hereon Group 3 will be referred to as
GPA6).
Figure 1. An outline of the study flow from the first appointment through to the end of participation. GPA: glucose and physical activity.
The 4+2-week design was used to identify how the patterns of
use might differ depending on how the technologies were
deployed. In particular, whether there were any additive benefits
to receiving a single device initially before receiving feedback
from the second device at a later point compared with being
given access to feedback from both devices from the start, and
how this affected their usage. This design was used to identify
how usage varied by how the devices were deployed.
The Fitbit provided feedback regarding the number of steps
taken, distance traveled, heart rate, calories expended, and flights
of stairs climbed. Similarly, the FreeStyle Libre app provided
feedback concerning glucose level (in mmol/L), direction of
glucose trend (increasing, decreasing, or stable), time in range
(above, below, or normal), and daily trends for individual days
as well as previous 7, 14, or 28 days. Example screenshots of
the feedback displayed by the FreeStyle Libre and Fitbit are
provided in Multimedia Appendix 2. Feedback from the
FreeStyle Libre was accessible via the smartphone app, and
feedback from the Fitbit was accessible via the wrist-worn
display and smartphone app. Both the FreeStyle Libre and Fitbit
were worn throughout the 6 weeks, but settings were restricted
or unrestricted, and monitors were masked or unmasked as per
group allocation. If a participant should not access physical
activity feedback during the study, the feedback was switched
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off (via the app, hiding the feedback icons normally displayed
and switching off notifications) or covered in tape (the
wrist-worn display). Restricting glucose feedback meant
participants wore the sensor (as normal) but did not scan it.
These participants were informed that the device was
automatically logging data in the background, but as they were
not scanning the sensor, no data were being stored and it was
considered a nonfunctioning monitor. If we allowed these
participants to scan the sensor, there was no way of restricting
their access to seeing feedback.
Fitbit monitors were initialized using the Fitbit app, and
minute-level data were downloaded via Fitabase (Small Steps
Labs LLC) and processed using Kinesoft version 3.3.80
(Kinesoft). A minimum of 3 FreeStyle Libre glucose sensors
were deployed to each participant, with each offering a lifespan
of 2 weeks. Glucose levels were captured by the LibreLink app
and extracted in 15-min epochs using Diasend (Diasend Inc).
Interstitial glucose levels were categorized as below range (<4.0
mmol/L), normal (4.0-5.9 mmol/L), or above range (>5.9
mmol/L) [16]. Scans were also characterized as rising quickly,
rising, changing slowly, falling, falling quickly, or no trend
arrow (determined by proprietary algorithms).
Participants were asked to ensure that the Fitbit had enough
charge and was synced regularly with the Fitbit app during the
intervention. Participants were notified when the battery level
reached <25% or if ≥5 days had passed since a previous sync
(both remotely monitored by the researchers using Fitabase).
For the FreeStyle Libre, participants were asked to scan the
sensor once every 7 to 8 hours to minimize data loss but were
not reminded by the researchers if they failed to adhere to this.
Scanning the sensor was the only way to access glucose
feedback by the participants.
Procedures
We deployed ActiGraph wGT3x-BT accelerometers (ActiGraph)
to measure physical activity over 7 consecutive days. These
were deployed over the right hip, midclavicular line. ActiGraphs
were initialized and downloaded using ActiLife (ActiGraph;
Multimedia Appendix 2). Participants met the UK physical
activity guidelines if they achieved a total of 150 min of
moderate-to-vigorous (or ≥75 min of vigorous) physical activity
in bouts of ≥10 min [17]. Participants were also asked to wear
a Fitbit at baseline with settings adjusted and masked
(notifications switched off and covered in tape) as to not provide
feedback. They were instructed to wear them during waking
hours and remove for water-based activities.
Self-reported age, sex, ethnic background, employment status,
household income, highest level of education, and home
postcode were recorded at baseline. Index of Multiple
Deprivation was calculated using home postcode and was then
segmented into 1 of the 10 categories ranging from ≤8.49 (least
deprived) to ≥34.18 (most deprived) [18]. Height and waist
circumference were measured. A digital scale (Tanita
MC780MA) was used to measure weight and body fat. HbA1c
was assessed using a point-of-care Afinion AS100 Analyzer
(Alere Inc), with prediabetes classified as having an HbA1c of
6.0% to 6.4% [19]. Resting blood pressure was recorded using
an Omron digital monitor (Omron Corporation).
From the start of the study, consecutive participants were invited
to take part in a semistructured interview after completing the
intervention. Interviews were completed at the 6-week follow-up
appointment by a member of the research team independent
from the quantitative data collection procedures and intervention
delivery.
Study Outcomes
Primary Outcome
Participant usage of the Fitbit and FreeStyle Libre were assessed
by time spent on the associated apps using Ethica Data
(Kitchener). Usage was also assessed by the frequency with
which participants scanned the FreeStyle Libre, the frequency
with which the Fitbit was synced, and the number (and type)
of changes to the physical activity goals. Before participants
left the appointment, verbal and written information was
provided about how to apply, activate, and scan the FreeStyle
Libre and how to sync and charge the Fitbit. Default Fitbit
physical activity goals were 10,000 steps, 30 active minutes,
10 flights of stairs, 2500 calories, and 8 kilometers per day. To
record changes to these goals, the researchers checked the
participant’s study-specific Fitbit accounts daily via the
Web-based Fitbit platform.
Secondary Outcomes
The indicators used to assess feasibility included the number
of individuals who accessed and completed the Web-based
survey, the number of individuals deemed eligible, uptake and
retention, the number of FreeStyle Libre sensors provided to
participants, and nonusage attrition [20]. Notes were made to
identify the number of additional sensors provided. For
acceptability, the indicators used were Fitbit wear time (defined
as the presence of a heart rate signal and not categorized as sleep
by Fitbit’s proprietary algorithm), the number of times the
research team prompted participants to sync or charge the Fitbit,
the number of minutes of missing data, and the proportion of
expected data for the FreeStyle Libre.
Sample Size Calculation
As typical with feasibility studies, no sample size was calculated,
but a target of 45 participants was prespecified [14]. This
approach was used because the trial sought to assess the
feasibility of the recruitment processes.
Statistical Analyses
Descriptive statistics were reported as mean (standard deviation)
or frequency (%) using Statistical Package for Social Sciences
version 24.0 (SPSS Inc). Semistructured interviews were
conducted at the final appointment, with a convenience sample
of 26 participants, and 5 further interviews were conducted to
confirm data saturation. Interviews were transcribed verbatim
and analyzed thematically with the support of NVivo software,
version 11 (QSR International PTY Ltd). Thematic analysis
comprised data familiarization; generating initial codes;
searching for, reviewing, defining, and naming themes; and
producing the report [21]. Members of the research team (MO
and FD) conducted initial coding. Randomly allocated subsets
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of transcripts were coded by the remaining team members to
ensure validity and consistency and to enhance interpretive
authenticity. Team members met during data analyses to review
emerging themes and to search for and collate participant views.
Participants were contacted via email to provide feedback to
ensure interpretations made by the team reflected the
experiences of the participants [22].
Results
Feasibility of the Trial
Eligibility, Uptake, and Retention
In total, 525 people visited the Web-based survey, 340 (64.8%)
individuals completed the survey, and 58 individuals (17.1%;
11% of those visiting the survey) were eligible for the study. A
total of 45 individuals (77.6% of those eligible) consented to
take part, and no participants withdrew from the study (Figure
2).
Figure 2. A flow chart of participant recruitment, enrollment and allocation for the study.
Participant Characteristics
The sample was made up of more females (60%), the
participants had a mean age of 56 (SD 8.7) years, and the
participants were predominantly white British (88.9%) (Table
1). Most participants (53.4%) had completed undergraduate or
postgraduate education, 19 (42.2%) had a household income of
≥£52,000, and 20 (44.4%) lived in a postcode considered least
deprived. A total of 7 participants (15.6%) were identified as
being at high risk of developing T2D, 3 (6.7%) were classified
as living with prediabetes, 17 (37.8%) were overweight, and 23
(51.1%) had obesity.
The sample was highly compliant with wearing the ActiGraph
and Fitbit during baseline. A total of 36 (80%) participants
recorded 7 valid days of wear, with an average of 6.6 valid days
and 861.5 min of daily wear recorded for the ActiGraph (Table
2). A total of 40 participants (88.9%) did not comply with the
UK physical activity guidelines, and an average step count of
6905 steps was recorded.
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Table 1. Participants’ baseline characteristics stratified by group.
Group 3: GPA6
(n=15)
Group 2: PA4GPA2
(n=15)
Group 1: G4GPA2
(n=15)
Total sample (N=45)Baseline characteristics
Demographics
53.9 (7)55.3 (9)58.8 (9)56 (9)Age (years), mean (SD)
12 (80)9 (60)6 (40)27 (60)Female gender, n (%)
Employment status, n (%)
11 (73)10 (67)9 (60)30 (67)Employed
2 (13)4 (27)4 (27)10 (22)Retired
2 (13)1 (7)2 (13)5 (11)Othera
Education level, n (%)
4 (27)3 (20)9 (60)16 (36)Postgraduate university
5 (33)0 (0)3 (20)8 (18)Undergraduate university
4 (27)9 (60)3 (20)16 (36)Some additional training
2 (13)3 (20)0 (0)5 (11)Completed secondary school
Household income (£), n (%)
0 (0)1 (7)3 (20)4 (8.9)>100,000
8 (53)4 (27)3 (20)15 (33)52,000-100,000
4 (27)7 (47)7 (47)18 (40)18,000-51,999
2 (13)2 (13)2 (13)6 (13)<18,000
1 (7)1 (7)0 (0)2 (4.4)Unknown
Index of multiple deprivation, n (%)b
7 (46.7)7 (46.7)6 (40)20 (44.4)Least deprived
2 (13.3)1 (6.7)0 (0)3 (6.7)Most deprived
Body composition, mean (SD)
30.4 (4)34.8 (9)29.6 (5)31.6 (7)Body mass index (kg/m2)
97.4 (13)108.4 (15)98.8 (14)101.5 (15)Waist circumference (cm)
Cardiometabolic health
2 (13)0 (0)1 (7)3 (7)Prediabetic, n (%)
5.6 (0.3)5.5 (0.3)5.6 (0.3)5.6 (0.3)Glycated hemoglobin (measured in %),
mean (SD)
128.5 (16)131.7 (16)135.9 (15)132 (16)Systolic BPc (mmHg), mean (SD)
82.3 (12)79.9 (9)82.7 (10)81.7 (10)Diastolic BP (mmHg), mean (SD)
aOther denotes looking after home and/or family, doing unpaid or voluntary work, or unable to work because of sickness or disability.
bPostcode deprivation offers 10 categories, but only the 2 most extreme categories have been presented for clarity.
cBP: blood pressure.
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Table 2. Participants’ baseline physical activity characteristics stratified by group.
Group 3: GPA6 (n=15)Group 2: PA4GPA2 (n=15)Group 1: G4GPA2 (n=15)Total sample (N=45)Physical activity char-
acteristics
ActiGraphFitbitActiGraphFitbitActiGraphFitbitActiGraphFitbit
6.5 (0.6)6.8 (0.4)6.5 (0.7)6.5 (0.8)6.8 (0.8)6.8 (0.8)6.6 (0.7)6.7 (0.7)Number of valid days,
mean (SD)
Valid day, n (%); cumulative %
8 (53); 5312 (80); 809 (60); 6010 (67); 6714 (93); 9314 (93); 9331 (69); 6936 (80); 807
6 (40); 933 (20); 1004 (27); 874 (27); 930 (0); 930 (0); 9310 (22); 91.17 (16); 96≥6
1 (7); 1000 (0); 1002 (13); 1000 (0); 930 (0); 930 (0); 933 (7); 980 (0); 96≥5
0 (0); 1000 (0); 1000 (0); 1001 (7); 1001 (7); 1001 (7); 1001 (2); 1002 (4); 100≥4
839.8 (80)851 (60.7)833.2 (74)832 (61.1)911.4 (88.5)912.4 (63.3)861.5 (86.9)865.1 (69.6)Wear time
(minute/day), mean
(SD)
362.5
(187.5)
—281.3 (123.1)—342.2 (107.6)—328.7 (144.6)
—
aCounts per valid wear
minute, mean (SD)
7748 (5148)8747 (5367)5637 (1963)7650 (4007)7331 (3433)9329 (4251)6905 (3776)8575 (4530)Step count per day,
mean (SD)
513.9
(103.2)
—536.6 (89.9)—569.9 (90.1)—540.1 (95.3)—Sedentary
(minute/day), mean
(SD)
288.7 (76.7)—271.4 (77.3)—304.4 (97.1)—288.2 (83.4)—Light physical activity
(minute/day), mean
(SD)
37.2 (40.5)—25.2 (18.6)—37 (21.2)—33.1 (28.4)—MVPAb (minute/day),
mean (SD)
15.8 (34.5)—5 (6.2)—9.6 (14.4)—10.1 (21.9)—MVPA in bouts ≥10
min (minute/day),
mean (SD)
2 (13)—1 (7)—2 (13)—5 (11)—Met physical activity
guidelinesc, n (%)
—36.9 (42.9)—43.5 (54.1)—39.5 (28.2)—39.8 (41.5)Active minutesc,d,
mean (SD)
—13.8 (11.7)—7 (6.4)—13.8 (8.2)—11.8 (9.5)Number of floors
climbedd, mean (SD)
—3.6 (1.2)—3.9 (1.6)—3.3 (1.7)—3.6 (1.5)Reminders to
moved,e,f, mean (SD)
aNot available from the device.
bMVPA: moderate-to-vigorous physical activity.
cActive minutes are calculated by Fitbit’s undisclosed proprietary algorithm but are said to represent activity of ≥3 Metabolic Equivalent of Task (METS)
and are only awarded if duration of activity is ≥10 consecutive minutes.
dActiGraph accelerometers do not capture a comparable variable.
eReminders to move track hourly step counts, and notifications delivered with a slight vibration are sent when the user does not reach 250 steps by 50
minutes of each hour (between 09:00 am-5:00 pm).
fNo notifications were active during this wear period; this intends to suggest how many would have been shown had the settings been unmasked.
Feasibility of the Technology: Quantitative Insights
A total of 22 participants (48.9%) completed the study using
the minimum number of 3 FreeStyle Libre sensors. Moreover,
11 of the 23 participants requiring extra sensors (47.8%) had 1
faulty or misplaced sensor, 8 (34.8%) had 2, 2 (8.7%) had 3,
and the remaining 2 (8.7%) had 4. A total of 262 displacements
were reported and there were more in groups G4GPA2 and
GPA6. It was noted that 27 participants (60%) set the LibreLink
app to remind them to scan the glucose sensor. There were no
instances of nonusage attrition.
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Feasibility of the Technology: Qualitative Insights
Participants evaluated the technologies (a main theme) and
discussed the usability, wearability, reliability, durability,
preferences, privacy, and cost (as subthemes). Additional quotes
to support the described subthemes are presented in Multimedia
Appendix 3.
Usability
Participants generally found both technologies easy to use, in
particular, how they found the Fitbit easy to charge and were
complimentary about the battery life. Comments relating to
applying the FreeStyle Libre emphasized the initial trepidation
felt by the participants, mostly because of the visible needle
and concern that the insertion process would be painful (across
all 3 groups). However, there was a pleasant surprise with which
the FreeStyle Libre adhered to the skin, and this nervousness
typically subsided following the first application. The
requirement of scanning the FreeStyle Libre at least every 8
hours to avoid data loss was highlighted as a flaw with the
technology, as some participants forgot to scan regularly enough,
and several participants noticed periods of missing data during
sleep:
I thought it was all very straightforward, all very easy.
[female, GPA6]
I can take it off at night and charge it at night so
there's no issues with that. I put it on charge every
second night really. Charging a Fitbit lasts about five
days so if I put it on every second night it was fine;
never had no issues with it running out at all. [male,
PA4GPA2]
I was pleasantly surprised that it didn’t hurt. When I
first saw the thing I thought, God this is going to be
awful and hurt my arm but I couldn’t believe how
painless it was. [female, GPA6]
When you go to sleep, seven hours isn’t all that long
really. You generally need more than seven hours’
sleep and not everybody would wake up in the night.
I do but not everybody would, so that wasn’t quite
long enough. [female, GPA6]
Wearability
The majority of the participants found the FreeStyle Libre
comfortable, with many forgetting the sensor was there
(particularly participants in groups G4GPA2 and GPA6). A few
indicated issues with skin irritation from the Tegaderm and
having trouble applying the sensor correctly. The issues with
the wearability of the sensor appear to relate more to participants
being self-conscious about wearing the sensor, with some
resorting to covering it up with additional or alternative clothing
and others suggesting refinements to the sensor and Tegaderm.
Similarly, participants across all groups noted that the design
of the Fitbit could be improved. In particular, participants
suggested aligning the design with traditional watches, and for
some, this issue meant they were not pleased when asked to
replace their existing jewelry with the Fitbit. Reasons for
discomfort were also related to the impact of temperature on
the Fitbit strap:
It was fine though, I think it’s brilliant. I forgot it was
even there and in fact I’m a bit lost without it now
it’s not there, it is quite strange. [female, GPA6]
It was more about that but when I had the glucose
monitor on, for a start, when it was hot, I put
sleeveless on but then I was getting, what’s that,
what’s that, what’s that? So, I started wearing things
with just sleeves on. [female, PA4GPA2]
Because I have got all these lovely watches at home
that I can’t wear, because I have got that. Somebody
at work has got one of those on, I noticed she has got
it on her other hand. She has got her watch on one
hand and her Fitbit on other hand. I thought well
that’s one way of doing it. But I couldn’t wear it on
there. [female, GPA6]
Reliability
Some participants questioned the glucose level provided by the
FreeStyle Libre when it classified them as low or in the red
when this was not normally the case. They tended to attribute
this observation to the timing of using a new sensor or altering
the location of the FreeStyle Libre on the arm. When talking
about the Fitbit, the accuracy of the data provided by the
technology was questioned (by the participants across all 3
groups), specifically for step count, calories, distance, mode of
activity, stairs climbed, heart rate, and sleep. During masked
Fitbit wear, very few problems with automatic syncing were
revealed, but during unmasked periods, many participants
reported the need for multiple attempts at manually syncing the
Fitbit. Similarly, multiple attempts were sometimes needed to
scan the FreeStyle Libre:
I think when I first got it, it was quite low actually for
the first…well for the first day, it was below the 4 and
I was thinking ooh but then it went down to the normal
sort of range. And actually, the last one a week ago
and the same thing actually, that’s been lower, I don’t
know if it’s the device or if I’ve done something
different or what. [female, G4GPA2]
I think sometimes it’s been quite generous with steps.
Turning around to get the towel is giving me steps
and some days it said, “you’ve walked ‘x’ miles” and
I thought, “I can’t have.” Some days it’s told me I’ve
walked eleven miles and I thought, “have I walked
eleven miles?” Eleven miles is quite a…so I’m not
sure it’s accurate to that extent. [male, G4GPA2]
I had a couple of issues…sometimes it's a bit difficult
to link it to my phone, it just takes a bit of
perseverance rather than everything happening on
one flick of the screen, it might take two or three
minutes just to catch on the Bluetooth. It's not a major
issue, it's just a little niggle, that's probably a better
word. [male, PA4GPA2]
Durability
Several participants spoke about their experience of having the
FreeStyle Libre sensor fall off, and, in part, this was because
they were getting less aware of wearing it as time went on (more
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so for participants in G4GPA2 and GPA6). Particular reasons
reported by participants included walking into door frames,
catching the FreeStyle Libre sensor on clothing, or showers and
perspiration weakening the sensor's attachment. Participants
also raised annoyances about the memory of the FreeStyle Libre,
suggesting that the memory is not sufficient, and perhaps, if it
lasted a day or two, it would avoid some of the data losses, as
some participants kept forgetting to scan it regularly:
I caught one on the car doorframe when I was getting
something in and out of the car. The other one, I
walked into a doorframe and caught it and it just bent
the needle and it stopped working. [male, GPA6]
I thought it might have a better memory, last a day
or two but because I kept forgetting to, because I am
so busy I just kept forgetting to scan it so there are
gaps and also at night time I go to bed like 9, 10
o’clock at night time and then get up sort of 12 hours
later after a really good sleep and there are huge
gaps. [male, G4GPA2]
Privacy
Participants discussed the topic of privacy, explaining how they
did not mind or have any problems with having data collected
on how much they used their phone and the study apps during
the study period. Some participants mentioned that this was
mainly because they had nothing to hide. Others raised concerns
about other apps and their monitoring activities, such as Google
Maps, which captures a lot of information about user location:
It was interesting that you could have all this stuff
going on on your phone but it also is a bit spooky as
well because people are watching your performance.
I suppose that, in real life, can be quite scary. It is
anyway - you don’t know who’s watching you at any
point. [female, GPA6]
Preference
Participants described accessing an array of feedback metrics
for their activity. Preferred Fitbit features were typically step
count and heart rate, with calories burned considered the least
meaningful. There were conflicting remarks about the Fitbit
prompts, the associated motivational messages were seen as
childish and receiving the notification to move hourly was
deemed too frequent. Nonphysical activity features such as food
logging and relaxation were not used as often or considered as
useful as the physical activity features of the Fitbit. This was
typically because of the manual entering of data required on the
app or preference for using alternative apps. The FreeStyle Libre
features were talked about positively by participants with no
clear preferences for the feedback provided. A suggested
improvement was for greater flexibility in viewing historical
data. There was an overall preference toward the FreeStyle Libre
compared with the Fitbit, mostly because of the novelty of
monitoring glucose levels (regardless of group):
I’d quite often look at my heartbeat because that was
the most interesting thing on there. [male, GPA6]
It gives you those daily reports which are helpful.
And I thought it was helpful that you could add in a
note when you had eaten something. So, you could
then align, I mean in the end you didn’t really need
to because you could see the patterns for yourself,
but to start with that’s useful that you could put in
when you had eaten something. Or put a note in of
some sort which is helpful. [female, PA4GPA2]
I have actually enjoyed the glucose monitor results,
looking at the graphs and charts more than the Fitbit.
[female, GPA6]
I could have delved a lot more deeply into the Fitbit
but I was more interested in the app and the glucose
levels…I’ve never monitored my glucose before and
I was fascinated by the whole thing. I was amazed
how the device worked and all sorts of things about
it. [male, G4GPA2]
Cost
Several participants expressed their concern about the cost of
the FreeStyle Libre sensors if they were to buy them, in
particular, because they only last 2 weeks, which would restrict
many people from accessing this technology:
It is a lot. I am sure they will come down as people
use them more and more, but, and they only last two
weeks, so you know it is a lot of money. [female,
PA4GPA2]
Acceptability of the Technology: Quantitative Insights
During the 6 weeks, 22 of 45 participants (48.9%) provided 42
days of valid Fitbit wear, with all participants averaging a total
of 40.1 (SD 3.2) valid days. Compliance with syncing the Fitbit
data noted that 12 participants (26.7%) received a prompt from
the researchers to sync (encourage data transfer), whereas 5
(11.1%), 3 (6.7%), 2 (4.4%), and 2 (4.4%) participants received
2, 3, 4, or 5 prompts, respectively. In terms of charging the
Fitbit, 9 (20%) participants received a prompt to charge the
Fitbit as battery status reached <25%. No data losses were
recorded for the Fitbit across the 3 groups. The level of data
capture for the FreeStyle Libre was high—an average of 87.6%
(SD 3.8) and 82% (SD 19) in the first and sixth week,
respectively—and this was relatively consistent between the 3
groups (Multimedia Appendix 4).
There was no clear trend toward increased physical activity over
the 6 weeks using step count, active minutes, number of flights
of stairs, or reductions in the number of reminders to move
(Multimedia Appendix 5). Similarly, there was no improvement
in interstitial glucose levels using time in range (Multimedia
Appendix 6).
Acceptability of the Trial: Qualitative Insights
Participants evaluated the study design (a main
theme)—specifically, having a positive experience, wanting
full access to feedback (in particular, participants in the groups
G4GPA2 and PA4GPA2), indicating the study duration being
too short, having issues with the eligibility criteria, and being
uncertain of what was expected of them (as subthemes).
Additional quotes to support the described subthemes are
presented in Multimedia Appendix 7.
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There was an overall sense of positivity in taking part in the
study. Indeed, participants wanted access to the information
provided by the technologies, with some explaining their
frustration of having devices masked and others describing their
disappointment with not being in GPA6. The 6-week duration
of the study was deemed not long enough by some participants
to gain a full understanding of the relationship between their
lifestyle and glucose, represent normal life, set more challenging
Fitbit goals, or try out different wear locations for the FreeStyle
Libre:
I really enjoyed it. I really learned a lot from it. [male,
G4GPA2]
Yes, I was really pleased that I was in the six-week
group because I thought that will give me a lot to go
on, whereas two weeks is kind of neither here nor
there. I thought six weeks is a reasonable amount of
time to assess things. I thought that was good for me
and it led me to sort of draw some conclusions about
glucose and how I was using it. [female, GPA6]
It is difficult to do that over six weeks. Perhaps over
several months you might be able to pin it down to
what you eat and when you eat it. Perhaps keeping a
food and exercise diary and linking them together,
but we weren’t asked to do that. [female, GPA6]
Some participants suggested that the FreeStyle Libre might be
better suited to individuals at greater risk of developing T2D
or people already with a diagnosis of diabetes. Only including
individuals with a compatible Android smartphone was
highlighted as an important limitation of the study:
I said to [the researcher] you would have to change
what app you use or something because I think you
potentially would get a lot more people involved with
it if it was compatible with an iPhone as well. [female,
GPA6]
There was uncertainty on 2 fronts—changing behavior and
engaging with the technology. There was some uncertainty
around whether participants felt that the study required them to
change their behavior or whether it was purely a monitoring or
data collection exercise:
If I had been told, like what we are looking for is you
to increase your activity because we are after this
certain, we are trying to see this thing, then I would
have gone for it. [male, G4GPA2]
There were also inconsistencies in participants' perceptions of
how much to engage with the technologies. Some individuals
suggested that receiving more instructions on how to use and
interpret the feedback would have been useful, whereas others
were happy about not being given too much guidance and felt
that the instructions given were clear. That said, participants
explained how explicitly being told to be more active or to eat
differently would have left them better placed to act on the
feedback. Other suggestions included directing people to sources
of information and being able to compare their glucose levels
against a healthy profile via the FreeStyle Libre app:
Perhaps a bit more detailed, again just how to just
sort of really make the best use of it would be better.
[female, PA4GPA2]
There’s not really that much information to go with
the monitor to tell you how to interpret the data.
[male, GPA6]
But [the researcher] did say at the start, use this as
you want it’s your, your thing to use as you want. So
that was good. [male, G4GPA2]
Technology Usage
From weeks 1 to 6, the groups G4GPA2 and GPA6 spent a lower
amount of time on the FreeStyle Libre app, going from 28.3 to
12.3 min per day and 11.5 to 5.5 min per day, respectively
(Table 3). PA4GPA2 participants logged 7.1 min per day in
week 5 and 4.7 min per day in week 6. A similar pattern was
observed for the FreeStyle Libre app whereby participants in
groups PA4GPA2 and GPA6 observed a reduction in time spent
on the Fitbit app, reducing from 6.7 to 3.4 min per day and 7.6
to 3.9 min per day, respectively. Similarly, participants in
G4GPA2 reduced their app usage from weeks 5 to 6 from 16.9
to 12.7 min per day (the only weeks when they could access it).
The average number of scans declined over time across all 3
groups (Figure 3). In the groups G4GPA2 and GPA6, participants
logged on average 9.4 scans per day in week 1 and 6.8 scans
per day in week 6. Across weeks 5 and 6, participants in
PA4GPA2 conducted 6.3 scans per day and 5.6 scans per day,
respectively. A number of Fitbit monitors unexpectedly restored
to default settings during deployment, resulting in syncs being
completed automatically.
A total of 13 of 45 participants (28.9%) changed ≥1 of the
physical activity goals from the default settings. Of these
participants, 9 (69.2%) changed the daily step goal, whereas
the number of floors, active minutes, calories, and distance goals
were changed by 5 (38.5%), 3 (23.1%), 2 (15.4%), and 2
(15.4%) participants, respectively. Notably, the daily step goal
was reduced by 7 participants (77.8%).
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Table 3. Pattern of app usage for the Fitbit and FreeStyle Libre.
Group 3: GPA6Group 2: PA4GPA2Group 1: G4GPA2App usage
Fitbit, mean (SD)
7.6 (3.8)6.7 (3.9)
—
aWeek 1, minutes per day
4.6 (3.9)5 (4.7)—Week 2, minutes per day
5.3 (5.0)3.9 (2.8)—Week 3, minutes per day
5.5 (3.7)3.1 (1.8)—Week 4, minutes per day
4.3 (3.3)3.5 (2.1)16.9 (16.4)Week 5, minutes per day
3.9 (3.4)3.4 (2.6)12.7 (13.6)Week 6, minutes per day
FreeStyle Libre, mean (SD)
11.5 (8.5)—28.3 (23.6)Week 1, minutes per day
7.7 (5.7)—21.7 (22.6)Week 2, minutes per day
7.7 (7.9)—17.6 (14.7)Week 3, minutes per day
6.3 (8.2)—13.2 (11.2)Week 4, minutes per day
6.0 (5.5)7.1 (3.9)8.2 (5.5)Week 5, minutes per day
5.5 (6.0)4.7 (6.4)12.3 (17.6)Week 6, minutes per day
aData not available.
Figure 3. Pattern of participant scans of the glucose sensor over the 6 weeks, with the horizontal line reflecting the recommended minimum number
of scans per day. One participant recorded 173 scans on day 12, deemed an outlier, and so was excluded from this figure. G4GPA2: Group 1; PA4GPA2:
Group 2; GPA6: Group 3.
Discussion
Principal Findings
To the authors’ knowledge, this is the first study to deploy both
behavioral and physiological self-monitoring digital health
technologies to individuals at risk of developing T2D. Use of
the devices reduced over the 6-week intervention period but
remained higher than the minimum level of use needed to avoid
data loss (eg, scanning the FreeStyle Libre every 8 hours).
Despite limitations with smartphone compatibility, it was
feasible to conduct the study with a high uptake rate and full
retention of participants at the end of the trial. The study and
technologies were acceptable to individuals at risk of T2D.
Specific Recommendations
This feasibility trial has identified several key areas for industrial
and research sectors to collectively consider when considering
the use of commercially available technologies in health
research. These include the following: the need to (1) integrate,
or facilitate the integration of, information collected by
behavioral and physiological sensors into a single platform and
(2) provide intelligent feedback and automated, actionable
insights by using multiple data sources in real time.
Technology Usage
Participants were given minimal instruction as to how to engage
with the technologies in an effort to reflect an off the shelf
deployment. There was reduced use of the Fitbit and FreeStyle
Libre over the 6-week intervention period, which was similar
between the 3 groups. This suggests that the provision of both
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technologies did not clearly impact the honeymoon period or
the novelty effect frequently observed when people newly access
digital health technologies [23]. For the FreeStyle Libre, the
magnitude of this novelty effect was different between time
spent on the app and the frequency of scanning. Scans per day
reduced by approximately 28% between week 1 and week 6,
whereas time spent on the app decreased by 52% to 57% for
both groups accessing the FreeStyle Libre for the full 6 weeks.
With participants expressing preference for more simple
feedback features, these data suggest that participants ended up
preferring to simply scan and see their current glucose levels
rather than delve into the more detailed feedback that could be
seen by the Freestyle Libre app [24,25]. This appeared to happen
once users were content with the instant, and perhaps more
understandable, feedback provided with each scan.
Stand-alone telemonitoring systems are an encouraging tool to
support motivation [26]. The dual deployment of physical
activity and physiological monitors succumbing to the issues
of disuse may have been because of the feedback sources treated
as distinct entities with distinct purposes. It has been noted
elsewhere that relationships between behavior and health vary
in how easily they can be detected by the individual [26]. This
means that it may be more difficult for people to notice the
benefits of being more physically active or having better blood
sugar control compared with, for example, improving asthma
medication adherence to relieve acute episodes of breathlessness
[27].
A potentially helpful technological development would be to
combine and relate the feedback provided by the Fitbit and
FreeStyle Libre (or other similar devices) into a single module
or feedback interface to better represent the acute relationship
between behavior and physiology. With such integration, the
technology may be more equipped to identify, display, and
describe teachable moments such as “the walk you have just
taken after eating bought your blood sugar back down to
baseline 20 minutes faster than if you had stayed sitting down.”
Elsewhere, teachable moments have been defined as naturally
occurring events that may motivate individuals to adopt positive,
risk-reducing behaviors [28]. However, the authors propose that
to display feedback showing the physiological consequences
of behavior, it might need to be handled in a slightly different
way to make it meaningful to the individual. Previous studies
have used glucose monitoring technology to show
activity-related reductions in glucose to adults living with T2D
[29]. The development of such biobehavioral feedback messages
will require sophisticated real-time machine learning techniques
to capture and process data to produce appropriate notifications
to users in an accurate and timely manner. Another provision
of teachable moments would be to demonstrate these
relationships under controlled conditions. The positive impact
of physical activity bouts on acute health in the laboratory
setting has been demonstrated [11,12] and can highlight key
stimulus-response events. Bailey et al [30] used intermittent
continuous glucose monitoring to show individuals with
prediabetes and T2D their blood glucose as a tool to increase
adherence to an exercise program over 8 weeks. However, this
approach would not be currently feasible at the population level,
which is where further technological development may still
play a key role.
Feasibility of the Trial and Technology
Eligibility of individuals completing the Web-based risk survey
was low (17%), with 63% of those who were ineligible for the
study classified as having a low risk of developing T2D and
32% having a noncompatible smartphone. Therefore, this
recruitment approach mostly attracted the worried well and may
benefit from more targeted strategies, such as recruiting from
primary care records that have identified 17.5% to 26.5% of
screened individuals presenting with impaired glucose regulation
[31,32]. However, since study completion, the FreeStyle Libre
is now compatible with iOS devices, eliminating the limitation
of smartphone compatibility that excluded many otherwise
eligible survey responders. This was also highlighted by
participants as a huge barrier to recruitment and a source of
selection bias. That said, once recruited, all participants
completed the study, describing their experience of taking part
as a positive one.
Characteristics of the participants also offer important insights
into the appropriateness of the recruitment strategy and
eligibility criteria. Although most participants were classified
as overweight or obese and did not meet physical activity
recommendations, less than one-fifth of the sample was deemed
at high risk, only 7% were prediabetic, and there was significant
ethnic homogeneity, with almost 90% of the sample being white
British, despite recruiting from an area with a multi-ethnic
population. This is particularly important given that South Asian
adults are 1.4 times more likely to develop T2D than white
British adults [33]. Therefore, the next trial must actively seek
more at-risk communities. After experiencing the FreeStyle
Libre for at least a couple of weeks, many participants saw the
glucose monitor as having great potential for people diagnosed
with T2D. The FreeStyle Libre has since been made available
on prescription by the NHS for people who meet a clear criterion
(including currently undertake intensive monitoring >8 times
daily and have an impaired awareness of hypoglycemia) with
nationwide availability from April 2019 [34].
Participants expressed the need for further instruction and
demonstration of the technologies and assistance with
interpreting the feedback. The reported uncertainty about
engaging with the technologies and hesitation in changing
behavior clearly demonstrate that simply providing people with
digital health technologies is insufficient for proactive lifestyle
modification [35]. Although this was not the primary aim of
the study, the minimal guidance approach to the study has
illuminated important issues with using sophisticated digital
devices in this way. The need for a human element in such
prevention approaches to provide education, demonstrate
devices, prescribe exercise, or motivate individuals to make
positive lifestyle changes is something current digital health
technologies cannot replicate or replace. In part, this may be
because interfaces are not adequately intuitive or because data
are not easily interpretable. Interviewees expressed difficulty
knowing whether their glucose pattern was normal and what
approaches they should take to improve it. Similarly, many
features of the Fitbit and FreeStyle Libre went unexplored or
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were regarded as surplus. Participants tended to focus on
features regarded as more palatable such as step count and heart
rate, which are often featured in wearable technologies [36].
Therefore, with ever more sophisticated commercially available
devices, important challenges are to ensure the information
provided to users is easily accessible, intuitive, and actionable.
Acceptability of the Trial and Technology
The technologies were perceived as comfortable and easy to
use, and there was much positivity around participants’
experience of the study, with some criticisms of the trial design
linked to wanting the study to last for longer than 6 weeks as
well as disappointment in not receiving the combined feedback
for the full length of the intervention period (ie, being allocated
to GPA6). Adherence to wearing the Fitbit was excellent, as
was charging compliance. However, issues with syncing the
Fitbit data left participants frustrated and led the authors to
conclude that syncing events should be interpreted with caution
and were not a suitable measure of usage.
The reliability of the feedback was also bought into question,
particularly the numbers presented by the Fitbit, which seemed
to classify extraneous arm movements as steps. A comparison
of baseline step count values from the Fitbit and research-grade
ActiGraph may suggest an overestimation from the Fitbit.
Commercially available monitors have shown strong correlations
with research-grade accelerometers [37], but this does not mean
numbers can be directly compared. Consequently, this perceived
or real overestimation may partly explain the lack of a clear
change in physical activity from baseline because of the potential
for a false sense of achievement. Similar notions, although to
a lesser extent, were made for the FreeStyle Libre. Some
participants noticed interdevice variability and the occasional
need for multiple scanning attempts, but most issues were related
to the visibility of the FreeStyle Libre and the aesthetics of the
device itself. The most common complaint of the FreeStyle
Libre was its durability, as supported by more than half of the
participants requiring at least one additional sensor. Previous
studies using the FreeStyle Libre have also noted concerns with
the adhesion of the sensors and have highlighted instances of
mild skin irritation and bruising often linked to medical-grade
adhesives [7,30]. Efforts to avoid the need for additional sensors
are needed to minimize disruption for patients and costs to the
NHS.
Strengths and Limitations
SIGNAL was the first study to deploy self-monitoring wearable
technologies presenting behavioral and physiological feedback
in real time to individuals at risk of developing T2D, classified
using a validated screening questionnaire. The mixed methods
design of the trial enabled real-life context to be applied to
quantitative data, permitting a more in-depth assessment of
participant’s perspectives toward the study design and digital
health technologies. The group allocations allowed all
participants to experience feedback from both devices, adding
to the breadth of experiences contributing to insights from the
qualitative interviews. The objective measurement of physical
activity allowed the sample to be compared against UK physical
activity guidelines.
In addition to the limitations previously disclosed, the study
had a relatively small sample size, limiting insight from
statistical analyses. Assessor and participant blinding to group
allocations was not possible. In addition, it was not possible to
quantify what participants specifically looked at within the Fitbit
and FreeStyle Libre apps. Owing to its main purpose as an
intervention tool, it was not possible to set up the FreeStyle
Libre in a masked mode (as achieved with the Fitbit).
Consequently, no glucose data were collected from the
PA4GPA2 group for the first 4 weeks of the intervention period.
Other studies have used the FreeStyle Libre Pro model that only
has a logging mode but is not currently available in all countries
[38].
Conclusions
SIGNAL, to the authors’ knowledge, was the first study to
explore levels of use when providing combined behavioral and
physiological self-monitoring wearable technologies to
individuals at risk of developing T2D. This study highlights
several important areas for future research, notably (1) the
inclusion of a more diverse pool of individuals at risk of
developing T2D or identified as living with prediabetes and (2)
the detection and presentation of teachable moments linking
behavioral choices with acute physiological consequences to
individuals in controlled and free-living settings. Improvements
to the usability, wearability, reliability, and durability are needed
before such approaches to disease prevention can be
implemented into routine health care. However, issues around
the integration of feedback from multiple sensors and the need
for real-time, actionable feedback need to be resolved for any
future trials.
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